Insiders · Profile

Moran Kyle

Chief Financial Officer at Wave Life Sciences. Filing since 16 Feb 2021. CIK 0001657765

Company

Date

Role

Action

Shares

Amount

Of holding

WVE Wave Life Sciences, Inc.

9 Feb 2026

Chief Financial Officer

Sold at will

3,588

$48.26K

2.6%

WVE Wave Life Sciences, Inc.

9 Dec 2025

Chief Financial Officer

Sold on a plan

50,036

$1.00M

35.9%

WVE Wave Life Sciences, Inc.

8 Dec 2025

Chief Financial Officer

Sold on a plan

210,000

$3.10M

70.2%

WVE Wave Life Sciences, Inc.

25 Sep 2024

Chief Financial Officer

Sold on a plan

17,146

$154.31K

46.4%

WVE Wave Life Sciences, Inc.

3 Apr 2024

Chief Financial Officer

Sold on a plan

15,630

$96.42K

31.5%

WVE Wave Life Sciences, Inc.

23 Aug 2023

Chief Financial Officer

Sold on a plan

37,062

$176.12K

44.6%

WVE Wave Life Sciences, Inc.

16 Feb 2023

Chief Financial Officer

Sold, plan not stated

9,729

$39.31K

10.9%

WVE Wave Life Sciences, Inc.

5 May 2022

Chief Financial Officer

Sold, plan not stated

5,021

$8.64K

5.6%

WVE Wave Life Sciences, Inc.

16 Feb 2022

Chief Financial Officer

Sold, plan not stated

9,204

$21.26K

11.0%

WVE Wave Life Sciences, Inc.

16 Feb 2021

Chief Financial Officer

Sold, plan not stated

1,722

$18.20K

2.4%

10 decisions on file.